TABLE 1.
Technology | Advantages | Disadvantages | |
---|---|---|---|
Concentration | Reverse osmosis and nanofiltration | • Effective removal • Small footprint • Relatively energy-efficient |
• Membrane scaling limits recovery |
Membrane distillation | • Effective removal of PFPeA | • Membrane fouling • Very early research stage • High thermal energy use |
|
Forward osmosis | • High rejection and recovery possible | • Draw regeneration difficult | |
RO-electrodialysis hybrids | • Possibly concentrate charged PFAS compounds | • No validation with PFAS | |
Foam fractionation | • Effective removal of long-chain PFAS, including PFOS | • Less effective for short-chain PFAS | |
Electrocoagulation | • Ease of operation • Effective removal of PFOA and PFOSwith Zn anode |
• Requires optimization ofoperational conditions • Passivation of electrode material |
|
Evaporation ponds | • Compatible with solar energy | • High land area requirement | |
• ZLD possible | • PFAS emissions to air possible | ||
Brine concentrators and crystallizers | • Significant concentration and ZLD possible | • High energy requirement • PFAS emissions to air possible |
|
Adsorption | • Reliable and easy to operate | • May require frequent regeneration and/or replacement of saturatedadsorbents | |
Coagulant aids | • Early data show high effectiveness | • Proprietary formulations | |
Defluorination | Biological treatment | • Could scale well | • Largely unsuccessful so far |
Ultraviolet irradiation | • Availability of equipment | • Ineffective for PFAA | |
Photocatalysis | • Effective degradation of PFOA • Reduce energy consumption by using visible light |
• May generate intermediates, such as PFHpA, PFHxA, PFPeA, PFBA, PFPA, and TFA • Proof-of-concept stage |
|
Advanced oxidation | • Moderate success with FTOHs | • Limited success with PFAS | |
Hydrated electrons | • Effective destruction of at least some PFAS | • Early stage | |
Plasma-based treatment | • Early evidence of effective defluorination | • Early stage | |
Electron beam | • High technology readiness level: previously used at full and pilotscales for wastewater and groundwater and commercially available in medical and pasteurization industries | • Large capital cost and high priceper volume treated • Needs further research onmembrane concentrate to understand matrix interferences |
|
• Effective at PFOA and PFOS degradation | |||
Zero-valent iron | • Effective with carbonate PFAS | • Less effective with sulfonate PFAS | |
Sonochemical treatment | • Complete mineralization of PFAS can be achieved without any pretreatment | • High energy input and scalability issues | |
Incineration | • Effective in desorption/destruction of PFAS | • Formation of by-products | |
Supercritical water oxidation | • Effective with many PFAS • Demonstrated at scale with PFAS-laden groundwater and leachate |
• High temperature and pressure create operational challenges | |
• Salts in membrane concentrates must be removed to prevent severescaling | |||
Sequestration | Deep-well injection | • Reliable sequestration | • Nondestructive |
Landfill | • Endpoint for solids | • Nondestructive • Impermanent sequestration due toPFAS-laden leachate production |
Note: For references, see the relevant section of the narrative.
Abbreviations: FTOHs, fluorotelomer alcohols; PFAA, perfluoroalkyl acid; PFAS, per- and polyfluoroalkyl substances; PFBA, pentafluorobenzoic acid; PFHpA, perfluoroheptanoic acid; PFHxA, perfluorohexanoic acid; PFOS, perfluorooctane sulfonic acid; PFPeA, perfluoropentanoic acid; PFPA, perfluoropropanoic acid; RO, reverse osmosis; TFA, trifluoroacetic acid.